← Leaderboards
William R Roush
University Of California San Francisco
$27,697,643
Attributed
$29,754,568
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$29,754,568 · 11
By mechanism
U54$14,241,407 · 1
R01$11,046,369 · 6
P01$2,308,773 · 3
R37$2,158,019 · 1
Top collaborators
- John L. Cleveland5 shared
- Derek Ronald Duckett1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Philip Jon Rosenthal$36,168,903
- Linda S Brinen$573,828
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadBasePropertyBiologicalDrug Design /Synthesis /ProductionAnalogCellsPharmaceutical ChemistryDesignComplexSmall MoleculeStructurePharmaceutical PreparationsGrantInhibitor/AntagonistGenerationsAntineoplastic AntibioticsDrug KineticsIn VivoStereochemistryBreast Cancer CellAntibioticsLinkEnzymes
Grant awards (58)
Lead Optimization to Support Cellular and Animal Studies$175,154
P01 · FY2021 · NS · contact PI
Lead Optimization to Support Cellular and Animal Studies$175,154
P01 · FY2020 · NS · contact PI
Lead Optimization to Support Cellular and Animal Studies$225,205
P01 · FY2019 · NS · contact PI
Lead Optimization to Support Cellular and Animal Studies$225,205
P01 · FY2018 · NS · contact PI
Development of in vivo active small molecule selective inhibitors of ASK1$598,284
R01 · FY2017 · GM
Lead Optimization to Support Cellular and Animal Studies$296,280
P01 · FY2017 · NS · contact PI
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics$598,617
R01 · FY2016 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics$491,992
R01 · FY2016 · CA · contact PI
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics$630,698
R01 · FY2015 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics$491,992
R01 · FY2015 · CA · contact PI
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics$747,603
R01 · FY2014 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics$484,305
R01 · FY2014 · CA · contact PI
SAR Analysis/Med Chem (Florida)$964,020
U54 · FY2013 · MH · contact PI
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics$744,805
R01 · FY2013 · CA
SAR Analysis/Med Chem (Florida)$2,927,855
U54 · FY2012 · MH · contact PI
SAR Analysis/Med Chem (Florida)$948,775
U54 · FY2012 · MH · contact PI
Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics$793,843
R01 · FY2012 · CA
SAR Analysis/Med Chem (Florida)$3,200,180
U54 · FY2011 · MH · contact PI
Natural Products Synthesis via Cycloaddition Reactions$417,229
R01 · FY2011 · GM · contact PI
SAR Analysis/Med Chem (Florida)$2,694,383
U54 · FY2010 · MH · contact PI
Natural Products Synthesis via Cycloaddition Reactions$406,331
R01 · FY2010 · GM · contact PI
Acyclic Diastereoselection: Methodology and Synthesis$388,998
R01 · FY2010 · GM · contact PI
SAR Analysis/Med Chem (Florida)$1,762,322
U54 · FY2009 · MH · contact PI
Natural Products Synthesis via Cycloaddition Reactions$410,435
R01 · FY2009 · GM · contact PI
Acyclic Diastereoselection: Methodology and Synthesis$388,998
R01 · FY2009 · GM · contact PI
SAR Analysis/Med Chem (Florida)$1,743,872
U54 · FY2008 · MH · contact PI
Natural Products Synthesis via Cycloaddition Reactions$410,435
R01 · FY2008 · GM · contact PI
SYNTHETIC CHEMISTRY$227,019
P01 · FY2008 · AI · contact PI
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$250,509
R37 · FY2007 · GM · contact PI
SYNTHETIC CHEMISTRY$224,528
P01 · FY2007 · AI · contact PI
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$209,053
R01 · FY2007 · GM · contact PI
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$143,168
R37 · FY2007 · GM · contact PI
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$257,991
R37 · FY2006 · GM · contact PI
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$249,443
R01 · FY2006 · GM · contact PI
SYNTHETIC CHEMISTRY$228,896
P01 · FY2006 · AI · contact PI
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$264,200
R37 · FY2005 · GM
SYNTHETIC CHEMISTRY$223,257
P01 · FY2005 · AI
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$190,282
R01 · FY2005 · GM
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$88,980
R01 · FY2005 · GM
SYNTHESIS OF POLYHDROXYLATED NATURAL PRODUCTS$271,800
R01 · FY2004 · GM
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$267,750
R37 · FY2004 · GM
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$253,343
R01 · FY2004 · GM
SYNTHETIC CHEMISTRY$196,339
P01 · FY2004 · AI
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$22,992
R01 · FY2004 · GM
SYNTHESIS OF POLYHDROXYLATED NATURAL PRODUCTS$271,800
R01 · FY2003 · GM
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$267,750
R37 · FY2003 · GM
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$245,022
R01 · FY2003 · GM
SYNTHESIS OF POLYHDROXYLATED NATURAL PRODUCTS$271,800
R01 · FY2002 · GM
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$241,069
R37 · FY2002 · GM
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$237,973
R01 · FY2002 · GM
SYNTHESIS OF INHIBITORS OF PARASITIC CYSTEINE PROTEASES$0
P01 · FY2002 · AI
SYNTHESIS OF POLYHDROXYLATED NATURAL PRODUCTS$272,325
R01 · FY2001 · GM
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$234,464
R37 · FY2001 · GM
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$231,450
R01 · FY2001 · GM
SYNTHESIS OF INHIBITORS OF PARASITIC CYSTEINE PROTEASES$0
P01 · FY2001 · AI
NATURAL PRODUCT SYNTHESIS VIA CYCLOADDITION REACTIONS$231,118
R37 · FY2000 · GM
ACYCLIC DIASTEREOSELECTION: METHODOLOGY AND SYNTHESIS$225,541
R01 · FY2000 · GM
SYNTHESIS OF INHIBITORS OF PARASITIC CYSTEINE PROTEASES$111,736
P01 · FY2000 · AI